Keywords: drug-eluting stent; malapposition; optical coherence tomography; stent coverageCSA, cross-sectional area(s); DES, drug-eluting stent(s); IVUS, intravascular ultrasound; NIH, neointimal hyperplasia; OCT, optical coherence tomography
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
p38 MAPK Inhibitor, CBS3830 Limits Vascular Remodelling in Arterialised Vein Grafts
Keywords: MAPKs, mitogen activated protein kinases; PCNA, proliferating cell nuclear antigen; CHD, coronary heart disease; NIH, neointimal hyperplasia; SMC, smooth muscle cells; PRRs, pattern recognition receptors; ERK, extracellular-signal regulated kinas; IH, int
Optical Coherence Tomography Versus Intravascular Ultrasound to Evaluate Coronary Artery Disease and Percutaneous Coronary Intervention
Keywords: intravascular ultrasound; optical coherence tomography; percutaneous coronary interventionFD-OCT, frequency-domain optical coherence tomography; IVUS, intravascular ultrasound; MLA, minimal lumen area; NIH, neointimal hyperplasia; OCT, optical coherence t
Quantitative and Qualitative Changes in DES-Related Neointimal Tissue Based on Serial OCT
Keywords: neointima; optical coherence tomography; stentCSA, cross-sectional area; DES, drug-eluting stent(s); EES, everolimus-eluting stent(s); NIH, neointimal hyperplasia; OCT, optical coherence tomography; PES, paclitaxel-eluting stent(s); SES, sirolimus-eluting
Spatial distribution of neo-intimal hyperplasia 6 months after zotarolimus-eluting stent implantation, analysed by optical coherence tomography
Keywords: Optical coherence tomography; Neointimal hyperplasia; Zotarolimus-eluting stentImagerie par cohérence optique; Hyperplasie néo-intimale; Stent actif au zotarolimusDES, drug-eluting stent; NIH, neointimal hyperplasia; OCT, optical coherence tomography; PES
Monitoring In Vivo Absorption of a Drug-Eluting Bioabsorbable Stent With Intravascular Ultrasound-Derived Parameters : A Feasibility Study
Keywords: coronary artery disease; intravascular ultrasound; quantification; stentsDES, drug-eluting stent(s); EEM, external elastic membrane; ICUS, intracoronary ultrasound; NIH, neointimal hyperplasia; PLLA, poly-l-lactic acid
Optical Coherence Tomography Assessment of In Vivo Vascular Response After Implantation of Overlapping Bare-Metal and Drug-Eluting Stents
Keywords: coronary artery disease; optical coherence tomography; percutaneous transluminal coronary angioplasty; stentBMS, bare-metal stent(s); DES, drug-eluting stent(s); IVUS, intravascular ultrasound; LST, late stent thrombosis; NIH, neointimal hyperplasia; OCT,
Vascular Effects of Sirolimus-Eluting Versus Bare-Metal Stents in Diabetic Patients: Three-Dimensional Ultrasound Results of the Diabetes and Sirolimus-Eluting Stent (DIABETES) Trial
Keywords: BMS, bare-metal stent; DIABETES, Diabetes and Sirolimus-Eluting Stent trial; EEM, external elastic membrane; ISA, incomplete stent apposition; IVUS, intravascular ultrasound; NIH, neointimal hyperplasia; SES, sirolimus-eluting stent
Pharmacologic inhibition of vein graft neointimal hyperplasia
Keywords: 18; 23; 29ACE, angiotensin-converting enzyme; CABG, coronary artery bypass graft; ET, endothelin; ICAM-1, intercellular adhesion molecule-1; MMP, matrix metalloproteinase; NIH, neointimal hyperplasia; NO, nitric oxide; ODN, oligodeoxynucleotide; PDGF, pla